On Wednesday shares of J C Penney Company Inc (NYSE:JCP) closed at $8.71. Company’s sales growth for last 5 years was -6.90%. J.C. Penney Company Inc (NYSE:JCP) will begin selling Sephora products online by later this month, Reuters reports, adding that the company plans to add more outlets in locations across the country.
Cerus Corporation (NASDAQ:CERS) in last trading activity moved down -1.68% to close at $4.69. Company weekly performance is 0.43% while its quarterly performance stands at -13.15%. Cerus Corporation (NASDAQ:CERS) is -33.29% away from its 52 week high. Cerus Corporation (NASDAQ: CERS) on 5 May, announced financial results for the first quarter ended March 31, 2015. Revenue for the first quarter of 2015 was $7.7 million, reflecting an increase in INTERCEPT disposable kit demand of 17% and a 2% decrease in reported revenue from the first quarter of 2014.
On last trading day Gilead Sciences Inc. (NASDAQ:GILD) advanced 0.79% to close at $106.39. Its volatility for the week is 1.81% while volatility for the month is 2.29%. GILD’s sales growth for past 5 years was 28.80% and its EPS growth for past 5 years was 39.10%. Gilead Sciences Inc. (NASDAQ:GILD) monthly performance is 4.09%. Life sciences company Abzena PLC on Wednesday said US biotechnology company Gilead Sciences Inc. (NASDAQ:GILD) is to move the GS-5745 antibody directly into a phase 3 clinical study in gastic cancer in the third quarter of this year.
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has 1.20% insider ownership while its institutional ownership stands at 97.10%. In last trading activity company’s stock closed at $13.97. Allscripts Healthcare Solutions Inc. (MDRX) on 7 May, reported a loss of $10.1 million in its first quarter. The Chicago-based company said it had a loss of 6 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and stock option expense, came to 8 cents per share. The electronic health records company posted revenue of $334.6 million in the period, which also missed Street forecasts. Twelve analysts surveyed by Zacks expected $347.7 million.
On last trading day Masimo Corporation (NASDAQ:MASI) advanced 0.06% to close at $34.51. Its volatility for the week is 2.73% while volatility for the month is 2.19%. MASI’s sales growth for past 5 years was 10.90% and its EPS growth for past 5 years was 8.10%. Masimo Corporation (NASDAQ:MASI) monthly performance is -0.63%. Masimo Corp. (NASDAQ:MASI) said Tuesday that California federal prosecutors have decided not to pursue charges against the company and current and former employees over its Pronto and Pronto-7 hemoglobin-testing devices after a yearlong investigation.